THN391

· Therini Bio Pty Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for THN391, covering 2024-12-19 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess THN391 in Subjects With Alzheimer's Disease [Phase 1]